Displaying 1 - 1 of 1
| Active Ingredient | PENTOXIFYLLINE |
| Therapeutic Class | HEMORRHEOLOGICS |
| Indications | Peripheral vascular disease. Pentoxifylline is indicated as an adjunct to surgery for treatment of intermittant claudication related to chronic occlusive arterial disease of the limbs. |
| Caution | May take 2-4 weeks to see onset of action. Hypotension, nausea, dizziness. |
| Dose Range | 400mg 2-3 times daily with meals. |
| Drug Interactions | |
| Pregnancy | Use with caution. |
| Breast Feeding | Pentoxifylline is distributed in breastmilk and is not recommended for lactating More ... |